Our Board

Mark Phillips

Mr Mark Phillips

BCom (Hons), MCom, FAICD

Chair of the Board, Cancer Council NSW representative on the Cancer Council Australia Board

Appointed to the Board in April 2013 and re-appointed in April 2016 

Mr Phillips has more than 30 years’ experience in business. In a 20-year career with the Commonwealth Bank of Australia, he was instrumental in the development of a range of new business divisions. Subsequently, Mr Phillips spent more than 10 years as the Chief Executive Officer of various companies listed on the Australian Securities Exchange and as an adviser to businesses and not-for-profit organisations. He is currently Chief Executive Officer of CatholicCare Sydney.

Nicholas Adams

Mr Nicholas Adams

BCom (Marketing)

Chair of the Fundraising and Marketing Committee

Elected to the Board in December 2015

Mr Adams is the Chief Market Manager at Allianz Australia Insurance and has 23 years’ experience in financial services and telecommunications marketing with companies such as Westpac, American Express and Bupa. He has expertise in customer relationship management (CRM), loyalty and digital marketing, and building data-driven marketing programs to drive both revenue and customer engagement with brands. At a community level, Mr Adams is involved with supporting the homeless through the St Vincent de Paul Society, and Weave, a not-for-profit group focused on disadvantaged and vulnerable young people, women, children and families in the City of Sydney and South Sydney.

Mr Adams was recognised as a Rising Star of Australian Marketing in 2004 and was named the Australian Direct Marketer of the Year in 2010. He was also identified as a Global Marketing Leader in 2011, 2012, 2013 and 2014 by the New York-based Internationalist Magazine.

James Butler

Mr James Butler

Member of the Remuneration and Nomination Committee, Chair of the Consumer Research Review Panel, Chair of the Relay For Life Steering Committee

Elected to the Board in December 2014 and re-elected in December 2017 

Mr Butler has been an active volunteer for Cancer Council NSW for almost 20 years, holding roles including Chair of the Hills Relay For Life Committee, and Chair of the Western Sydney Cancer Advocacy Network. He is a trained Cancer Council NSW advocate. As a two-time cancer survivor, he understands the need to influence decision-makers around key issues that have an impact on people affected by cancer.

Mr Butler is currently Chair of Cancer Council NSW’s Consumer Research Review Panel and the Hills Community Cancer Network. Mr Butler has also been a business owner for 25 years and is an active consumer representative on cancer services committees in the Western Sydney Local Health District.

Dr Toby Heap

Dr Toby Heap

BAppSc, MCom, PhD, GAICD

Chair of the Investment Committee, Member of the Audit and Risk Committee, Member of the Fundraising and Marketing Committee 

Elected to the Board in December 2015  

Dr Heap is a Founding Partner of H2 Ventures, a venture capital investment firm. He is a Non-Executive Director of not-for-profit fintech hub Stone & Chalk, equity crowdfunding platform Equitise, and is the Chair of the independent dance organisation Shaun Parker & Company. He is a member of The University of Sydney Alumni Council and holds a PhD in Health Sciences from The University of Sydney.

Previously a founder of several digital startups, Dr Heap was a Research Fellow at The University of Sydney, a member of the Australian Securities and Investment Commission’s Digital Finance Advisory Committee and a Non-Executive Director of SPELD NSW – a not-for-profit association supporting children and adults with specific learning difficulties.

Professor Lisa Horvath

Professor Lisa Horvath 


Board Director Representative on the Cancer Research Committee

Appointed to the Board in April 2015

Professor Horvath is the Director of Medical Oncology and Inaugural Director of Research at the Chris O’Brien Lifehouse. She completed medical school at The University of Sydney and trained in medical oncology at Royal Prince Alfred Hospital, where she was appointed to the senior staff in 2003. She completed her PhD in translational research at the Garvan Institute of Medical Research in 2004.

Professor Horvath’s research interest is predominantly in the field of prostate cancer biomarkers and therapeutics and she is involved in a large number of clinical trials in prostate and colorectal cancers, as well as Phase I trials. She holds academic appointments at both The University of Sydney and UNSW, and is the Head of Clinical Prostate Cancer Research at The Kinghorn Cancer Centre/Garvan Institute of Medical Research. Professor Horvath has also published more than 70 research papers in peer-reviewed journals in the past 16 years. 

Christine Howard

Ms Christine Howard 

B.Soc.Sc, Dip.App.Sc, Mid, MAICD

Member of the Fundraising and Marketing Committee

Elected to the Board in December 2017 

Ms Howard has 20 years of health management experience with a specific interest in understanding and responding to the health needs of rural areas. She has a background in nursing, midwifery and occupational rehabilitation before moving to executive management at the Riverina Division of General Practice in 2010. This organisation evolved into the Murrumbidgee Primary Health Network covering 124,000 square kilometres in south west NSW. As Executive Manager Planning, Commissioning and Performance, Ms Howard has ensured that primary health services funded through the network have been delivered in direct response to findings from the regional health needs assessments. The health burden of cancer in rural and regional areas continues to present as a significant challenge and one that Ms Howard is passionate about changing.

Dr John Laker

Dr John Laker AO

BEc (Hons 1) (Syd), MSc (Econ) PhD (London), HonDSc (Syd)

Chair of the Governance Committee, Chair of the Audit and Risk Committee, Member of the Remuneration and Nomination Committee 

Elected to the Board in December 2014 and re-elected in December 2017 

Dr Laker was Chairman of the Australian Prudential Regulation Authority (APRA), the regulator of the Australian financial services industry, from 2003 to 2014. An economist by training, Dr Laker had an extensive career in the Reserve Bank of Australia before his appointment to APRA, both in Australia and London, and has also worked in the Commonwealth Treasury and the International Monetary Fund (IMF).

Currently, Dr Laker is an External Expert for the IMF and has participated in a number of reviews of major banking systems. He is Chairman of The Banking and Finance Oath Limited and a member of the Council of the University of Technology, Sydney, as well as Australian Securities and Investment Commission’s External Advisory Panel. He also lectures at The University of Sydney. Dr Laker was made an Officer of the Order of Australia in 2008 and has won other professional awards for his services to the regulation of the Australian financial system.

Professor Jane Young

Professor Jane Young 


Chair of the Cancer Research Committee

Appointed to the Board in June 2016

Professor Young trained in medicine in the United Kingdom in 1983, undertook a Master of Public Health in 1998 and completed a PhD in applied epidemiology at The University of Sydney in 2000. She holds joint appointments with The University of Sydney, where she is Professor in Cancer Epidemiology; and Sydney Local Health District, where she is Executive Director of the Surgical Outcomes Research Centre, and Executive Director, Research for the Institute of Academic Surgery at Royal Prince Alfred Hospital.

Professor Young is a health services researcher with a focus on applying epidemiological methods to improve cancer services and patient outcomes. She has undertaken research spanning the cancer journey, and has an interest in surgical trials as well as developing and evaluating new models of care, promoting evidence-based practice and using data to improve cancer service delivery. She has co-authored over 200 peer-reviewed journal articles.